Pharmaceutical Grade Lactose Market Size, Share & Trends Analysis Report By Type (Crystalline Monohydrate Lactose, Inhalation Lactose, Granulated Lactose, Spray Dried Lactose), By Region, And Segment Forecasts, 2024 - 2030

Pharmaceutical Grade Lactose Market Size, Share & Trends Analysis Report By Type (Crystalline Monohydrate Lactose, Inhalation Lactose, Granulated Lactose, Spray Dried Lactose), By Region, And Segment Forecasts, 2024 - 2030

Pharmaceutical Grade Lactose Market Growth & Trends

The global pharmaceutical grade lactose market size is expected to reach USD 2.82 billion by 2030, as per the new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.5% from 2024 to 2030. This is attributable to the growing demand for novel medicines across the globe. Novel medicines, also known as new or innovative medicines, refer to pharmaceutical products that are newly developed and differ significantly from existing medications. These medicines often involve breakthrough discoveries or advancements in medical science and technology. Novel medicines may include biologics, new chemical entities (NCE), targeted therapies, gene therapies, and immunotherapies. The development of such novel medicines and drugs is driven by a high level of R&D activities being carried out by various drug manufacturing companies around the world.

Additionally, pharmaceutical formulations often require various excipients and manufacturers have a range of options to choose from alternative excipients that offer similar functionality and cost advantages may compete with the product, reducing its market demand. For example, according to JRS PHARMA, EMDEX shows great potential as a viable alternative to spray-dried lactose, as it exhibits comparable characteristics in terms of powder and tableting properties.

The pharmaceutical-grade lactose industry is characterized by intense competition, with multiple companies vying for market share and supplying the product to a wide range of end-users globally. To achieve a competitive edge, it is essential to focus on product launches, expansion, and research and development initiatives. As a result, leading manufacturers operational in the market strive to obtain high level of dominance by undertaking numerous initiatives.

Pharmaceutical Grade Lactose Market Report Highlights

• The crystalline monohydrate lactose type segment dominated the market with a revenue share of 28.0% in 2022. This is attributable to its high purity, solubility, and flow properties, which make the product a popular choice for manufacturers aiming to ensure the safety and efficacy of their pharmaceutical products.
• The lactose particles used in DPIs are usually in the range of 15-90 microns to carry out efficient delivery of inhaler medicine to the lungs.
• Increasing spending on the healthcare/pharmaceutical sector throughout the world is poised to have a positive impact on the global pharmaceutical lactose industry.
• North America dominated the industry with a revenue share of 28.9% in 2022. This is attributed to the presence of well-established players across the region, such as Pfizer, Johnson & Johnson, and Merck.

Please note The report will be delivered in 2-3 business days upon order notification.